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Effects of vitamin D supplementation 
on pulmonary function in 
postmenopausal women following 
an aquatic exercise program
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ABSTRACT
Objective: This study sought to investigate the effects of vitamin D supplementation and aquatic 
exercise on pulmonary function in postmenopausal women. Materials and methods: This prospective 
and controlled study included 104 women (62 ± 6.5 years) divided into three groups: a control group 
lacking vitamin D and calcium supplementation which remained sedentary (CG; n = 17); a control 
group receiving vitamin D and calcium supplementation which remained sedentary (CDG, n = 33); 
and a group that completed aquatic exercises three times a week and received vitamin D and calcium 
supplementation (DTG, n = 54). Data before and after 6 months of the study were analyzed, including 
serum 25-hydroxyvitamin D (25(OH)D) and calcium concentrations, peak expiratory flow (PEF), 
forced vital capacity (FVC), and cirtometry. Results: We observed significant increases in 25(OH)D 
concentrations in CDG (52.9 ± 2.4 to 69.1 ± 2.2; nmol/L; p < 0.0001) and DTG groups (55.5 ± 3 to 71.5 ± 
3 nmol/L; p < 0.0001). PEF increased by 7 ± 2% (p = 0.0080) in CDG group and 11 ± 2% (p < 0.0001) in 
DTG group, whereas FVC increased by 7 ± 2% (p = 0.0016) in the CDG group and 10 ± 2% (p < 0.0001) 
in the DTG group, whereas CG had no changes in any of these parameters. The increment value of 
cirtometry in DTG group (+43 ± 3%) were significantly (p < 0.0001) higher than those in CG (−4 ± 8%) 
and CDG (+4 ± 9%) groups. Conclusion: Our data suggest that vitamin D supplementation improves 
pulmonary function parameters in postmenopausal women. Arch Endocrinol Metab. 2017;61(1):28-35
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INTRODUCTION
T he large increase in longevity in humans during the last century raised new issues in health care, 
especially the control of aging-related deterioration 
(1). Intense efforts have been exerted to obtain 
new knowledge that can lead to the progression 
of chronic degenerative diseases and to slow the 
functional impairment, including deterioration of 
lung function (2). Vitamin D and calcium are among 
the potential factors related to maintaining bone and 
muscle health, and they cannot be separated from 
osteoporosis prevention in postmenopausal women. 
Vitamin D produced in the skin via the action of 
sunlight is converted into calcitriol, a potent hormone, 
which is important for health. Although its most 
common effects are on bone metabolism and mineral 
homeostasis, its receptors have been identified in 
almost all tissues, suggesting that it might have other 
roles (3,4).
Lung function also appears to be influenced by 
vitamin D concentrations, with cross-sectional studies 
identifying associations of lower plasma concentrations 
of 25-hydroxyvitamin D (25(OH)D) with worse lung 
function parameters (5,6). During aging, a gradual 
decline in the respiratory system occurs, the related 
factors of which include increased lung compliance, a 
decreased number of alveoli, and respiratory muscle 
weakening, as well as rib cage deformities caused by 
increased thoracic kyphosis because of, among others, 
vertebral fractures (2). 
Co
py
rig
ht
©
 A
E&
M
 a
ll r
ig
ht
s r
es
er
ve
d.
29
Pulmonar function in postmenopausal women
Arch Endocrinol Metab. 2017;61/1
Different regular physical activities, including water 
aerobics, have been used to preserve cardiorespiratory 
and musculoskeletal functions during aging (7). 
Moreover, research showed that the treatment of 
vitamin D deficiency in menopausal women can confer 
musculoskeletal benefits and reduce fall and vertebral 
fracture rates (8,9). In addition, aquatic exercise studies 
have also identified beneficial effects on pulmonary 
function in elderly women (10,11).
While conducting a protocol to test the effects of 
a differentiated water aerobics program (HydrOS), an 
opportunity arose to investigate the effects of vitamin D 
supplementation alone or in combination with high-
intensity aquatic exercises on pulmonary function in 
postmenopausal women.
MATERIAL AND METHODS
Subjects
This was a post hoc analysis of a protocol designed to 
evaluate the effects of a high-intensity water aerobics pro-
gram (HydrOS) in postmenopausal women (12). The 
initial study population consisted of women living in the 
city of Barueri, São Paulo who were previously sedentary 
and attending a service center for the elderly (Parque da 
Maturidade de Barueri) and who were selected from 
volunteers willing to participate in the study according 
to the following inclusion criteria: postmenopausal for 
≥ 5 years, non-institutionalized, and able to understand 
and respond to commands during the physical and cog-
nitive tests. The exclusion criteria were: any physical con-
ditions that might affect their performance in the physi-
cal tests (hypothyroidism, primary hyperparathyroidism, 
severe osteoarthritis, rheumatic arthritis, edema or ulcer 
in the lower limbs); chronic kidney disease (serum cre-
atinine > 1.4 mg/dL); diseases that could interfere with 
bone quality or neuromuscular functions; recent history 
of hip fracture (< 2 years); thyroid-stimulating hormone 
level < 0.05 or > 5.5 μIU/mL; dependence on alcohol, 
tobacco, or illicit drugs; currently receiving treatment 
with steroids, bisphosphonates, calcitonin, or vitamin D 
and its metabolites; use of estrogen or selective estrogen 
receptor modulators; use of drugs that could interfere 
with postural stability or vitamin D metabolism; uncon-
trolled high blood pressure; use of a prosthesis; regular 
physical activity in the last 6 months; serious heart dis-
ease; or complications during exercise stress testing that 
contraindicated physical activity. 
The research protocol, as well as the informed consent 
form, was duly approved by the Ethics Committee of 
Unifesp (No. 1771/2008). All volunteers who agreed to 
participate in the study provided written consent.
Design
In this prospective and controlled trial the preselec-
tion resulted in a group of 134 previously sedentary 
women. Of them, 26 were excluded on the basis of the 
described criteria (Figure 1). The 108 remaining partici-
pants (58.8 ± 6.4 years) were randomly divided into two 
groups. The vitamin D control group (CDG, n = 33) 
was maintained without regular physical training, and 
the trained group (DTG, n = 54) participated in the Hy-
drOS protocol over 6 months During the study period, 
both groups received supplementation with 1000 IU of 
vitamin D3 and 500 mg of elemental calcium daily. Ac-
cording to the same inclusion and exclusion criteria, a 
control group of 17 age-matched women with similar 
clinical characteristics was created. This group did not 
receive vitamin D nor participate in any physical activity 
program during the same period. The study design and 
the flow of subjects can be seen in Figure 1.
Figure 1. Flow of participants throughout the study. 
134 postmenopausal women participated in
the initial explanatory lecture
Randomization
108 pre-tests
Was created
control group
(CG) = 17
without any
intervention
104 women post-tests
Control Group (CG) = 17
Vitamin D Group Control
(CDG) = 33
Trained Group (DTG) = 54
Vitamin D control group (CDG) = 44
No pratice of regular 
physical exercise
1000 IU of vitamin 
D3 and 500 mg
of elemental calcium daily
CDG
11 subjects dropped out:
2 personal problems
1 moved away from the city
1 died after
Gallbladder surgery
7 were excluded due to
inadequate pulmonary
function test
DTG
10 subjects dropped out:
3 personal problems
1 was run over by a car
1 had a bowel surgery
5 were excluded due
to inadequate pulmonary
function test
Trained group (DTG) = 64
Aquatic exercise 3 times/weeks
for 24 weeks
1000 IU of vitamin D3
and 500 mg of elemental
calcium daily
26 excluded: 1 in use of bisphosphonate
1 primary hyperparathyroidism
13 restrictive osteoarthritis
8 personal problems
3 cardiovascular risk
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The post hoc analysis included only patients who 
completed the study and who met the acceptance 
criteria of the American Thoracic Society for the analysis 
of pulmonary function tests (CG, n = 17; CDG, n = 33; 
and DTG, n = 54). 
Supplementation
Prior to the start of the protocol, calcium intake in all 
groups was evaluated by a nutritionist through 24-h 
diet recall (13) and the daily calcium intake was similar 
among the groups. None of the participants received 
more than 600 mg of calcium daily. 
The volunteers in the control group were told 
to not change their lifestyle or consume any vitamin 
supplement during the observation period. Under 
medical supervision, the CDG and DTG groups 
received one tablet daily containing 1000 IU of 
cholecalciferol (vitamin D) and 500 mg of elemental 
calcium (as calcium carbonate) after breakfast. The 
participants were instructed to maintain their usual diet. 
During the intervention period with supplementation, 
the protocol adherence rate was 94% (SD ±3).
Parameters analyzed
The selected subjects were evaluated via anamnesis, 
functional capacity tests, spirometry, fasting blood 
collection, and bone densitometry tests to evaluate 
body composition. Those who did not undergo all 
procedures and measures or attend at least 85% of the 
planned sessions were excluded from the study.
Total calcium and 25(OH)D
All volunteers underwent fasting blood collection. A 
radioimmunoassay method (DiaSorin, Stillwater, MN, 
USA) was used to determine serum 25(OH)D levels. 
The intra- and interassay coefficients of variation (CVs) 
were 5.6 and 10%, respectively. An enzymatic colori-
metric method (ADVIA 1650, Bayer Ltd., Tokyo, Ja-
pan) was used to measure plasma levels of total calcium 
(CaT), with intra- and interassay CVs of 1.30 and 1.95%, 
respectively.
Anamnesis and physical examination
Medical and family history, ethnicity, diet, alcohol in-
take, smoking, and current medications were searched 
via anamnesis. The initial physical activity level of each 
participant was checked using the International Physi-
cal Activity Questionnaire, short version, already duly 
validated (14).
Body composition
Total body mass (kg) and height (cm) were obtained 
using an analog scale accurate to 0.1 kg (Filizola model 
31, Filizola, São Paulo, SP, Brazil). Body composition 
was examined via whole-body dual energy X-ray ab-
sorptiometry (DXA) using a densitometer with a dual 
emission X-ray source (Hologic Model Discovery A, 
Waltham, MA, USA). All procedures involving DXA 
were performed in the Osteometabolic Diseases Clinic 
of Unifesp Endocrinology Course, and the acquisition 
of the exams was systematically performed using the 
same technique and analyzed by the same examiner.
Pulmonary function
Pulmonary function was assessed by spirometry using a 
digital portable spirometer (One Flow; Clement Clarke 
International, England). Patients were previously in-
structed about the testing process. Each individual was 
positioned sitting while wearing a nose clip with her 
feet flat on the floor and head in a neutral and raised 
position. After the explanation, the subject immediately 
performed a maximal inspiration, followed by forced 
expiration with the tube placed on the tongue between 
the teeth and the lips clenched to prevent perioral leaks. 
At least six full spirometric maneuvers were performed 
until the difference between the latest maneuvers was 
< 5%. The best result was employed for the analyses 
following the American Thoracic Society guidelines 
and meeting the acceptability and reproducibility crite-
ria (15). The data were automatically transferred to an 
Amazon PC computer using software provided by the 
equipment manufacturer (ONE FLOW SOFT; Clem-
ent Clarke International, England). The following 
variables were considered: peak expiratory flow (PEF), 
forced expiratory volume in the first second of the ma-
neuver (FEV1), and forced vital capacity (FVC).
The chest expansion evaluation was conducted via 
dynamic cirtometry at the axillary level using a 1-cm-
wide measuring tape in 0.5-cm increments. The test 
was performed with each participant in a standing 
position, and the tape was placed at the axillary level 
around her bare chest. Each participant was instructed 
to perform a maximum expiration and inspiration, and 
the difference in centimeters between the two torso 
circumference values was recorded.
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Exercise protocol
The exercise sessions occurred three times a week 
in in a covered swimming pool with a depth of 
1.20–1.40 m and temperature of 29–31°C located in 
Parque da Maturidade de Barueri, São Paulo. During 
the lessons, we asked the participants to stand in the pool 
so that the water was near the xiphoid process. To control 
the training intensity, three heart rate sensors (RS100 
BLK; Polar, Finland) were used by three different 
students in each session so that at the end of 6 months, 
all participants had already used the heart rate sensor 
several times. In addition, the participants were taught 
how to use a Borg CR-10 category scale of perceived 
exertion (ranging from 0 – nothing at all, to 10 – very, 
very hard) used along with the measurement of the heart 
beat rate of the participants during the sessions (12).
During the lessons, we observed that the heart rate 
shown on the heart rate sensors was equivalent to the 
grade given by the participants on the Borg CR-10 
scale. At every stage of the protocol, various muscle 
groups (chest and back, biceps and triceps, shoulders, 
quadriceps and posterior thigh, hip adductors and 
abductors, and calf and abdominals) were trained. The 
workout routine was gradually changed from two to 
five repetition sets of the same exercise, e.g., two sets of 
30 s each, then moving on to three sets of 20 s each, 
followed by four sets of 15 s each, and ending with five 
sets of 10 s each. For the cardiorespiratory exercises, we 
used the Borg scale adapted as follows: 60% maximum 
heart rate (MHR), scale level 6 for 16 minutes of the 
session; 70% MHR, scale level 7 for 13 minutes of the 
session; 80% MHR, scale level 8 for 9 minutes of the 
session; and 90% MHR, scale level 9 for 7 minutes of 
the session (12). After the 6-month intervention period 
with a resistance aquatic exercise program, all tests were 
repeated in the three groups.
Statistical analysis
For all statistical analyses, the results were considered 
significant at p < 0.05. The Kolmogorov-Smirnov 
test was used to test data normality. The other nor-
mally distributed parameters were compared in two 
manners: intragroup before and after the study using 
Student’s t-test for matched samples; and intergroup 
before and after the study using Student’s t-test for 
independent samples. The chi-square test was used to 
verify the distribution of the different races of the 3 
groups. One-way analysis of variance and Tukey’s post 
hoc test were used when necessary to identify statisti-
cal differences.
RESULTS
Table 1 shows that the three groups were similar at base-
line in terms of biometric characteristics, total calcium, 
and body composition. The racial distribution (white 
and no white) did not differ between groups (p = 0.056).
After 6 months of study, serum 25(OH)D levels 
similarly increased in the two groups supplemented 
with vitamin D3 (p < 0.001). The mean value in the 
CDG group increased by 21% (from 52.9 ± 2.4 to 
69.1 ± 2.2; nmol/L, p < 0.0001), in the DTG group 
increased by 23% (from 55.5 ± 3 to 71.5 ± 3 for 3 
nmol/L, p < 0.0001), and in the CG group did not 
change significantly (from 50.1 ± 2.6 to 49.82 ± 2.4 
nmol/L, p= 0.4605) (Figure 2).
Table 1. Clinical features and anthropometric characteristics of the three groups at baseline and study completion 
Variable
Control Group (n = 17) Vitamin D Group (n = 33)  Trained Group (n = 54)
Before After % Before After % Before After %
Age 59.9 ± 2 58 ± 0.8 59 ± 6
Weight (kg) 70 ± 3 70 ± 3 0.2 ± 0.4 74 ± 2 75 ± 3 1.3 ± 0.6 73 ± 2 73 ± 2 0.7 ± 0.4
Height (cm) 1.59 ± 2 1.59 ± 2 - 0.01 ± 0.1 1.56 ± 1 1.56 ± 1 0.12 ± 1 1.56 ± 0.1 1.56 ± 0.1 0.22 ± 0.6
BMI (kg/m2) 27 ± 0.1 27 ± 0.1 0.23 ± 0.40 30 ± 0.7 30 ± 0.8 0.87 ± 0.51 29 ± 0.7 29 ± 0.7 -0.48 ± 0.78
Fat mass (kg) 26 ± 1.7 26 ± 1.8 -7.0 ± 6 29 ± 1.6 29 ± 1.7 -1.3 ± 1.3 28 ± 1.1 28 ± 1.2 -1.0 ± 2
Lean mass (kg) 42 ± 17 42 ± 16 -0.5 ± 1 42 ± 16 44 ± 12 4 ± 3 43 ± 10 43 ± 10 0.8 ± 1
Fat% 37 ± 1.3 36 ± 1.5 - 1 ± 1 38 ± 1.0 38 ± 1.1 -1.5 ± 0.8 38 ± 0.7 38 ± 0.7 -1 ± 0.8
Cirtometry (cm) 2.05 ± 0.3 2.04 ± 0.2 -4 ± 5a 2.12 ± 0.14 2.45 ± 0.16 4 ± 9a 2.21 ± 0.13 3.93 ± 0.16* 43 ± 3b
Ca T (RV: 8.5-10.5 mg/dL) 9.23 ± 0.43 9.14 ± 0.28 -0,9 ± 2 9.50 ± 0.23 9.20 ± 0.31 -3,2 ± 4 9.61 ± 0.33 9.40 ± 0.39 -2,2 ± 3
Values are expressed as the mean ± SE of the biometric measurements and total serum calcium (CaT) levels of the control (CG), control with vitamin D and calcium supplementation (CDG), and 
training (DTG) groups before and after the intervention. * p < 0.0001, indicate differences detected using Student’s t-test versus before the intervention. Different letters indicate statistically significant 
differences (p < 0.05) on one-way analysis of variance (Tukey’s post hoc test) in relation to the percentage change between the groups. BMI, body mass index. RV = Reference values. * p < 0.05.
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There were similarly significant improvements in 
PEF (L/m) and FVC (L) in both groups treated with 
vitamin D3 (CDG and DTG) regardless of physical 
training, whereas changes were not observed in the 
CG group (Figure 3). Although FEV1 values were 
higher at the end of study than the baseline values 
Figure 2. Evolution of serum 25-hydroxyvitamin D (25(OH)D) levels. Values are expressed as the mean ± SE of 25(OH)D levels in the control (CG), control 
with vitamin D and calcium supplementation (CDG), and training (DTG) groups before and after the intervention. * p < 0.0001, indicate differences 
detected using Student’s t-test versus before the intervention.
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in the vitamin D-supplemented groups, this change 
did not reach statistical significance (Figure 3). The 
measure of chest expansion (dynamic cirtometry), 
however, revealed a significant improvement only 
in the group that underwent physical training 
(Table 1). 
Figure 3. Evolution of pulmonary function test data during the study in the three groups. Values are expressed as the mean ± SE and percentage change 
for peak expiratory flow (PEF), forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV
1
) in the control (CG), control with vitamin D and calcium 
supplementation (CDG), and training (DTG) groups before and after intervention. * p < 0.0001 and # p < 0.01, indicate differences detected using 
Student’s t-test versus before the intervention.
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DISCUSSION
This study is a by-product of a broader protocol that 
assessed the effects of a high-intensity water aerobics 
program in postmenopausal women using several phys-
ical and laboratory parameters (12,16). Our results 
demonstrated that daily treatment with 1,000 IU of 
vitamin D3 for 6 months effectively produced a sig-
nificant increase in plasma 25(OH)D concentrations in 
most of the volunteers. In our study, this increase on 
25(OH)D levels was associated with an improvement 
in pulmonary function expiratory parameters (measure 
by spirometry), even in sedentary women, regardless 
of no participation in the aquatic exercise program. 
The trained group, additionally, was the only group 
to display improvement in the expandability parameter 
measured by cirtometry, suggesting some effect of wa-
ter aerobics on this parameter (12). We have to point 
out that all volunteers had age-related normal values 
on spirometry at baseline, and both Vitamin D-treated 
groups improved similarly their expiratory parameters, 
not seen in the control group (CG). A possible explana-
tion for the similar results on the pulmonary function 
parameters of DTG and CDG would be related to the 
increased respiratory muscle mass. The greater dynamic 
compression (restrictive) of the airways would lead to 
the fall of the flows measured at nozzle (17). The same 
dose of supplementation (1,000 IU/day) was used in 
another study (18) which was able to induce a signifi-
cant increment on serum levels of 25(OH)D after 3 
months (+17,6 nmol/L, in average).
The correlations between vitamin D metabolism 
and respiratory function have been widely studied in 
the literature (6). However, the results are not yet 
conclusive (19); rather, they remain rare in prospective 
intervention studies, and to our knowledge, no 
study has examined postmenopausal women without 
previous lung disease. In a randomized prospective 
double-blind study, supplementation with vitamin D 
in asthmatic children reduced the risk of exacerbations 
triggered by acute respiratory infection and significantly 
improved FEV1 values (20). Another prospective study 
in patients with chronic obstructive pulmonary disease 
(COPD) and vitamin D deficiency observed increases 
in respiratory muscle strength, reductions in the degree 
of dyspnea, and superior physical performance after 1 
year of vitamin D supplementation (21).
Several studies observed an increased prevalence of 
inadequate vitamin D levels in patients with different 
respiratory diseases such as asthma, COPD, tuberculosis, 
and a number of infections of the respiratory system 
(22-24). In observational studies such as the NHANES 
cohort, a cross-evaluation of 14,000 adults uncovered 
a significant association between higher 25(OH)D 
levels and better results for FEV1 and FVC (5). Similar 
results were observed by other authors in 1315 Chinese 
children (25). A Danish longitudinal study that 
followed 18,507 patients of different age groups for 20 
years found that lower serum 25(OH)D concentrations 
were associated with worse pulmonary function and an 
accelerated decline in FEV1 and FVC parameters (6).
Studies have indicated that respiratory epithelial 
cells express 1α-hydroxylase, which is responsible for 
the conversion of 25(OH)D to its biologically active 
form 1,25(OH)2D3, as well as the specific receptor 
for vitamin D (VDR) (26,27). Cross-sectional and 
prospective studies uncovered evidence associating 
the actions of vitamin D with increased surfactant 
substance levels and reduced inflammation in the 
respiratory tissues via VDR expressed in the airways 
(28,29). Besides, there is evidences for the action of 
vitamin D on the immune system, by increasing levels 
of LL-37 (cathelicidin), a peptide capable of promoting 
innate immunity and inducing the destruction of 
infectious agents, including Mycobacterium tuberculosis 
and influenza virus (19,29,30). 
In addition, some studies linked the actions 
of vitamin D to inhibited proliferation of 
metalloproteinases of the extracellular matrix (ECM) 
as well as the balance of type III collagen synthesis by 
fibroblasts (31). The ECM of lung tissue plays a key 
role in the structure and mechanical properties of the 
lungs, thus reflecting pulmonary function (5,32).
Studies in rats evaluated the direct effects of vitamin 
D on lung growth, and they observed an increased lung 
volume and improved pulmonary function in these 
animals. These results were obtained by analyzing the 
forces generated by the elastic recoil of the lungs in 
rats with vitamin D deficiency by plethysmography 
and histological analysis of the lung tissue, respectively 
(28). Rats born to females not supplemented with 
vitamin D displayed structural changes, such as a 
significant increase in airways resistance, and changes 
in mesenchymal differentiation markers of the trachea 
compared to rats born to supplemented females (33). 
The direct effects of active vitamin D on lung tissue 
observed in these experimental studies could explain 
our findings in this population of women supplemented 
with vitamin D, even in the absence of physical training 
(CDG group).
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The improvement observed via cirtometry only in 
the DTG group suggests that high-intensity aquatic 
exercises can increase chest expansion, probably 
by strengthening breathing muscles (17). This 
improvement may be associated with the influence of the 
physical properties of water, which increase voluntary 
breathing. The immersion of a subject in a liquid 
medium to the level of the xiphoid process promotes 
an increase of 60-65% in the work of breathing caused 
by increased resistance to thorax expansion produced 
by hydrostatic pressure and an increased blood volume 
in the thorax (34,35). This positive effect of the aquatic 
environment appears to favor the process of inspiratory 
force, as demonstrated by some studies in healthy 
elderly subjects (34). 
Despite these findings, this project has limitations 
such as the discrepancy among the sample sizes, 
particularly the smaller number of individuals in the 
control group. A fourth group without vitamin D 
supplementation subjected exclusively to an aquatic 
exercise program could be used to evaluate the isolated 
effects of exercise on pulmonary function. There were 
no surveys conducted on the time of sun exposure of 
the study participants. However, the samplings were 
performed all on the same occasions, therefore, we 
can suppose that the potential seasonal variations of 
Vitamin D were similar in the 3 groups, although we 
have not controlled the individual quantity of exposure 
to sunlight. Another limiting factor was the lack of 
an assessment of respiratory muscle strength through 
measurements of inspiratory and expiratory pressures. 
In conclusion, vitamin D supplementation was 
associated with improved spirometric parameters in 
postmenopausal women independent of participation 
in an aquatic exercise program. Aquatic exercises in 
turn increased chest expansion in the trained group. 
Based on our findings in addition to related literature, 
there are strong evidences that Vitamin D can play a 
role on pulmonary function. The increase of Vitamin 
D levels could also be a supporting measure for the 
strategies employed for preventing and treating diseases 
that impair pulmonary function. 
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